[1]
2025. Hyperthermic vs normothermic mitomycin C for intermediate-risk NMIBC: a real-world retrospective cohort study. Archivio Italiano di Urologia e Andrologia. 97, 4 (Nov. 2025). DOI:https://doi.org/10.4081/aiua.2025.14167.